Table 1.
Subject | Sample type | Viral load (IU/mL) | Description | Research question / challenge | Background described in |
---|---|---|---|---|---|
1 | CSF | 6.15E+03 | patient had encephalitis of unknown origin with atypical symptoms, HEV infection retrospectively identified through HTS | Typing, Virus variant/mutation causative for CNS symptomatic? | this study (study previously mentioned in [39]) |
2 | FFPE sample from a liver biopsy | ~1E+04* | liver biopsy obtained after rejection of transplant, stored as FFPE mounted on a microscope slide for >5 years at room temperature | Typing, Sequencing of HEV from a degraded FFPE sample stored under improper conditions | Hillebrandt et al., unpublished |
3 | serum | 4.18E+04 | HEV detected in an Irish blood donation, subtyping through fragment sequencing failed | Typing, New variant/genotype that caused subtyping to fail? | [30] |
4 | serum | 6,96E+03 | HEV genotype 7 from a camel sampled in 1983 | Obtaining a genome of a serum sample as old as ~ 40 years with repeated freeze-thaw cycles | [40] |
5a | serum | 2.46E+06 | chronic HEV infection in a n immunocompromised patient with fatal outcome | Compartment-specific subpopulation that contributed to patients’ clinical outcome? (Subpopulation with) ribavirin resistance mutations? Intra-host viral evolution? High background of host nucleic acids. |
unpublished/this study |
5b | duodenum | 1.74E+06 | |||
5c | liver | 1.86E+06 | |||
5d | medulla oblongata | 5.62E+06 |
Due to the FFPE fixation this concentration is an estimate.